Your browser doesn't support javascript.
loading
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
Keilholz, U; Ascierto, P A; Dummer, R; Robert, C; Lorigan, P; van Akkooi, A; Arance, A; Blank, C U; Chiarion Sileni, V; Donia, M; Faries, M B; Gaudy-Marqueste, C; Gogas, H; Grob, J J; Guckenberger, M; Haanen, J; Hayes, A J; Hoeller, C; Lebbé, C; Lugowska, I; Mandalà, M; Márquez-Rodas, I; Nathan, P; Neyns, B; Olofsson Bagge, R; Puig, S; Rutkowski, P; Schilling, B; Sondak, V K; Tawbi, H; Testori, A; Michielin, O.
Afiliación
  • Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: clinicalguidelines@esmo.org.
  • Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Dummer R; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
  • Robert C; Department of Dermatology, Gustave Roussy, Villejuif, France; Paris-Saclay University, Le Kremlin-Bicêtre, France.
  • Lorigan P; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
  • van Akkooi A; Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Arance A; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Blank CU; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Chiarion Sileni V; Department of Experimental and Clinical Oncology, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.
  • Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark; University of Copenhagen, Copenhagen, Denmark.
  • Faries MB; Department of Surgery, The Angeles Clinic, Cedars Sinai Medical Center, Los Angeles, USA.
  • Gaudy-Marqueste C; Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital De La Timone, Marseille, France.
  • Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Grob JJ; Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital De La Timone, Marseille, France.
  • Guckenberger M; Department of Radio-Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Haanen J; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hayes AJ; Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
  • Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Lebbé C; AP-HP Dermatology, Université de Paris, Paris, France; INSERM U976, Hôpital Saint Louis, Paris, France.
  • Lugowska I; Early Phase Clinical Trials Unit, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Mandalà M; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.
  • Márquez-Rodas I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
  • Nathan P; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Olofsson Bagge R; Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden; Wallenberg Centre for Molecular and Translational M
  • Puig S; Dermatology Service, Hospital Clínic of Barcelona and University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; CIBER, Instituto de Salud Carlos III, Barcelona, Spain.
  • Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Schilling B; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
  • Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.
  • Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Testori A; Department of Dermatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Michielin O; Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland.
Ann Oncol ; 31(11): 1435-1448, 2020 11.
Article en En | MEDLINE | ID: mdl-32763453
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología Médica / Melanoma Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología Médica / Melanoma Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article